Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Navaton Vet
- Development stage
- Unknown
- Lead developer
- Navana Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Navaton Vet is a veterinary nutritional preparation developed and marketed by Navana Pharmaceuticals. Formulated as an oral solution, it contains a combination of essential B-complex vitamins (B1, B2, B6, B12), D-panthenol, nicotinamide, inositol, choline chloride, folic acid, and the amino acid DL-methionine. Navaton Vet is primarily indicated for poultry and livestock to support liver function, alleviate liver dysfunction (such as fatty liver syndrome), and mitigate heat stress. Additionally, it helps increase appetite and metabolism, improve egg production, enhance the feed conversion ratio (FCR), and prevent ascites.
- Brand names
- Navaton Vet
- Other names
- Polymix Navaton Vet
Beyond the preview
Go deeper on Navaton Vet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Navaton Vet.